Benitec Biopharma (BNTC) Cash & Equivalents (2019 - 2026)
Benitec Biopharma (BNTC) posted Cash & Equivalents of $180 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 84.2% from $97.74 million a year earlier.
Powered by 
Analysis
Benitec Biopharma (BNTC) Cash & Equivalents (2019 - 2026) Analysis & Trends
Since fiscal Q4 2019, Benitec Biopharma has reported Cash & Equivalents for 27 quarters.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of 55.5% (FY2021 to FY2026).
- In prior fiscal years, Benitec Biopharma's Cash & Equivalents was $97.74 million in FY2025 (+92.2%), $50.87 million in FY2024, $2.48 million in FY2023 (-39.0%) and $4.06 million in FY2022 (-79.5%).
- Quarterly Cash & Equivalents has run from a low of $2.48 million in fiscal Q4 2023 to a high of $188.8 million in fiscal Q2 2026 over five years.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was fiscal Q2 2025, with growth of 283.8%; the weakest was fiscal Q4 2022, with a decline of 79.5%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Benitec Biopharma | 402.73 Mn | -158.32 Mn | - | 180.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 180.00 Mn |
| Dec 31, 2025 | 188.80 Mn |
| Sep 30, 2025 | 94.50 Mn |
| Jun 30, 2025 | 97.74 Mn |
| Mar 31, 2025 | 103.60 Mn |
| Dec 31, 2024 | 78.30 Mn |
| Sep 30, 2024 | 67.84 Mn |
| Jun 30, 2024 | 50.87 Mn |
| Dec 31, 2023 | 20.40 Mn |
| Sep 30, 2023 | 25.90 Mn |
| Jun 30, 2023 | 2.48 Mn |
| Mar 31, 2023 | 6.60 Mn |
| Dec 31, 2022 | 10.54 Mn |
| Sep 30, 2022 | 16.53 Mn |
| Jun 30, 2022 | 4.06 Mn |
| Mar 31, 2022 | 8.63 Mn |
| Dec 31, 2021 | 12.33 Mn |
| Sep 30, 2021 | 15.73 Mn |
| Jun 30, 2021 | 19.77 Mn |
| Mar 31, 2021 | 11.99 Mn |
API Access
Benitec Biopharma Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BNTC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "BNTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BNTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();